Eskildsen S. F., Coupe P., Fonov V., Manjon J. V., Leung K. K., Guizard N., Wassef S. N., Ostergaard L. R., Collins D. L., Breitner J., Alzheimer's Disease Neuroimaging Initiative (2012). BEaST: brain extraction based on nonlocal segmentation technique, NeuroImage, 59(3), 2362-73. Find out more.

Etchamendy N., Konishi K., Pike G.B., Marighetto A., Bohbot V. (2012). Evidence for a virtual human analog of a rodent relational memory task: A study of aging and fMRI in young adults, Hippocampus, 22(4), 869-880. Find out more.

Farley S., Dumas S., El Mestikawy S., Giros B. (2012). Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801, Neuropharmacology, 62(1), 503-17. Find out more.

Gauthier S. (2012). Management of Alzheimer’s disease using disease-modifying drugs., Neurodegener Dis, 2, 1-4.

Gauthier S., Patterson C., Chertkow H., Gordon M., Herrmann N., Rockwood K., Rosa-Neto P., Soucy J. P. (2012). 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia, Can J Neurol Sci, 39(6 Suppl 5), S1-8. Find out more.

Gauthier S., Patterson C., Chertkow H., Gordon M., Herrmann N., Rockwood K., Rosa-Neto P., Soucy J. P. (2012). Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4), Can Geriatr J, 15(4), 120-6. Find out more.

Gauthier S., Wu L., Rosa-Neto P., Jia J. (2012). Prevention strategies for Alzheimer's disease, Transl Neurodegener, 1(1), 13. Find out more.

Hawrylycz M. J., Lein E. S., Guillozet-Bongaarts A. L., Shen E. H., Ng L., Miller J. A., van de Lagemaat L. N., Smith K. A., Ebbert A., Riley Z. L., Abajian C., Beckmann C. F., Bernard A., Bertagnolli D., Boe A. F., Cartagena P. M., Chakravarty M. (2012). An anatomically comprehensive atlas of the adult human brain transcriptome, Nature, 489(7416), 391-9. Find out more.

Hong Y., Hay D. L., Quirion R., Poyner D. R. (2012). The pharmacology of adrenomedullin 2/intermedin, British journal of pharmacology, 166(1), 110-20. Find out more.

Ihl R., Ferris S., Robert P., Winblad B., Gauthier S., Tennigkeit F. (2012). Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease, Int J Geriatr Psychiatry, 27(1), 15-21. Find out more.

Jones A., McMillan M. R., Jones R. W., Kowalik G. T., Steeden J. A., Deanfield J. E., Pruessner J., Taylor A. M., Muthurangu V. (2012). Adiposity is associated with blunted cardiovascular, neuroendocrine and cognitive responses to acute mental stress, PLoS One, 7(6), e39143. Find out more.

Kovacevic T., Skelin I., Minuzzi L., Rosa-Neto P., Diksic M. (2012). Reduced metabotropic glutamate receptor 5 in the Flinders Sensitive Line of rats, an animal model of depression: an autoradiographic study, Brain Res Bull, 87(4-5), 406-412. Find out more.

Krantic S., Goutagny R., Cavanagh C., Chabot J.G., Colby-Milley J., Williams S., Quirion R. (2012). Nouveaux gènes impliqués dans la mémoire: impact sur la maladie d’Alzhiemer, Annales Académie nationale de médecine, 59-66.

Krantic S., Isorce N., Mechawar N., Davoli M.A., Vignault E., Albuquerque M., Chabot J. G., Moyse E., Chauvin J.P., Aubert I., McLaurin J., Quirion R. (2012). Hippocampal GABAergic neurons are susceptible to amyloid-beta toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model, J Alzheimers Dis, 29(2), 293-308. Find out more.

Kremen W. S., Lachman M. E., Pruessner J., Sliwinski M., Wilson R. S. (2012). Mechanisms of age-related cognitive change and targets for intervention: social interactions and stress, J Gerontol A Biol Sci Med Sci, 67(7), 760-5. Find out more.

Lee C. T., Leoutsakos J. M., Lyketsos C. G., Steffens D. C., Breitner J., Norton M. C. (2012). Latent class-derived subgroups of depressive symptoms in a community sample of older adults: the Cache County Study, Int J Geriatr Psychiatry, 27(10), 1061-9. Find out more.

Lee W. J., Tsai C. F., Gauthier S., Wang S. J., Fuh J. L. (2012). The association between cognitive impairment and neuropsychiatric symptoms in patients with Parkinson's disease dementia, Int Psychogeriatr, 24(12), 1980-7. Find out more.

Leoutsakos J. M., Muthen B. O., Breitner J., Lyketsos C. G. (2012). Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial, Int J Geriatr Psychiatry, 27(4), 364-74. Find out more.

Leuzy A., Gauthier S. (2012). Ethical issues in Alzheimer's disease: an overview, Expert Rev Neurother, 12(5), 557-567. Find out more.

Liu F., van der Lijn F., Schurmann C., Zhu G., Chakravarty M., Hysi P. G., Wollstein A., Lao O., de Bruijne M., Ikram M. A., van der Lugt A., Rivadeneira F., Uitterlinden A. G., Hofman A., Niessen W. J., Homuth G., de Zubicaray G., McMahon K. L., Thompson P. M., Daboul A., Puls R., Hegenscheid K., Bevan L., Pausova Z., Medland S. E., Montgomery G. W., Wright M. J., Wicking C., Boehringer S., Spector T. D., Paus T., Martin N. G., Biffar R., Kayser M. (2012). A genome-wide association study identifies five loci influencing facial morphology in Europeans, PLoS Genet, 8(9), e1002932. Find out more.